|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,389.20 INR | +0.43% |
|
-0.81% | -8.03% |
| 06-11 | Cipla's Goa, India Facility Receives VAI Status from US FDA | MT |
| 06-09 | Indian cancer patients battle shortage of key drugs as platinum costs surge | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- CIPLA Stock
- Consensus Cipla Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
